Fair!
$Recursion Pharmaceuticals(RXRX.US$ Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.42) by 7.14 percent. This is a 14.71 percent decrease over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $13.491 million which beat the analyst consensus estimate of $12.650 million by 6.65 percent. This is a 11.18 percent increase over sales of $12.134 million the same period last year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
